Cite
HARVARD Citation
Spikes, L. et al. (2022). BREEZE: Open‐label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension. Pulmonary circulation. p. n/a. [Online].